Birznieks Gunther insider trades
Birznieks Gunther has filed 10 Form 4s with the SEC that we hold, all for Vanda Pharmaceuticals Inc. (VNDA), as SVP, Business Development. Across all of them we count 0 purchases worth $0 and 7 sales worth $704.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($350.9K). The largest single trade was a sale of 42,431 shares of Vanda Pharmaceuticals Inc. worth $350.9K, dated 2026-03-02. The first filing on our record is dated 2022-03-02 and the latest 2026-03-04.
Vanda Pharmaceuticals Inc. (VNDA)
SVP, Business Development · 10 filings · 7 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-03-01 | S, sale reported on Form 4 | 4,084 | $45.7K | 2022-03-02 | SEC |
| 2022-03-02 | S, sale reported on Form 4 | 11,517 | $129.8K | 2022-03-02 | SEC |
| 2023-03-02 | S, sale reported on Form 4 | 8,509 | $52.8K | 2023-03-06 | SEC |
| 2023-03-03 | S, sale reported on Form 4 | 8,268 | $51.8K | 2023-03-06 | SEC |
| 2024-03-04 | S, sale reported on Form 4 | 8,727 | $37.5K | 2024-03-06 | SEC |
| 2024-03-05 | S, sale reported on Form 4 | 8,684 | $35.9K | 2024-03-06 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 42,431 | $350.9K | 2026-03-04 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1702031) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
